Cytotoxic potential of phenothiazines

Current Drug Targets

Volumn 7, Issue 9, 2006, Pages 1055-1066

  Motohashi, Noboru ^a   Kawase, Masami ^b   Satoh, Kazue ^c   Sakagami, Hiroshi ^d  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^b MATSUYAMA UNIVERSITY   (Japan)

^c SHOWA UNIVERSITY   (Japan)

^d MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

Author keywords

AIDS; Antitumor; Blast Transformation; CPZ nucleotide systems; Radical Scavenging Activity; Tumor Necrosis Factor (TNF)

Indexed keywords

10 METHYL 12H BENZ[A]PHENOTHIAZINE; 10 METHYLBENZ[C]ACRIDINE; 12H BENZ[A]PHENOTHIAZINE; 2 CHLORO 5 OXO 5H PHENOTHIAZINE; 5 OXO 5H BENZ[A]PHENOTHIAZINE; 5H BENZ[A]PHENOTHIAZIN 5 ONE; 6 HYDROXY 5 OXO 5H BENZ[A]PHENOTHIAZINE; 6 METHYL 5 OXO 5H BENZ[A]PHENOTHIAZINE; 6 METHYL 5H BENZ[A]PHENOTHIAZIN 5 ONE; 7 METHYLBENZ[C]ACRIDINE; 7,10 DIMETHYLBENZ[C]ACRIDINE; 7,9,10 TRIMETHYLBENZ[C]ACRIDINE; 9 METHYL 12H BENZ[A]PHENOTHIAZINE; ACICLOVIR; ACRIDINE DERIVATIVE; ACRIDINE ORANGE; ACTINOMYCIN DERIVATIVE; BENZ[A]PHENOTHIAZINE DERIVATIVE; BENZ[C]ACRIDINE DERIVATIVE; BENZ[O]PHENOXAZINE DERIVATIVE; CHLORPROMAZINE; DIBENZEPIN; IMIPRAMINE; MONOMETHYLBENZ[C]ACRIDINE; PHENOTHIAZINE DERIVATIVE; PHENOXAZINE DERIVATIVE; PSYCHOTROPIC AGENT; PYRIDO[3,2 A]PHENOXAZINE; THIAZINE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; BLAST TRANSFORMATION; CELL DIFFERENTIATION; CYTOTOXICITY; DRUG POTENCY; DRUG POTENTIATION; HUMAN; MACROMOLECULE; MULTIDRUG RESISTANCE; MUTAGENICITY; NONHUMAN; REVIEW; TRANQUILIZING ACTIVITY;

ANIMALS; ANTINEOPLASTIC AGENTS; DNA FRAGMENTATION; HUMANS; PHENOTHIAZINES; PSYCHOTROPIC DRUGS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33748509728     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945006778226624     Document Type: Review

References (76)

1. Motohashi, N.(1988) Antitumor activities of phenothiaiznes. In: Gupta R. R., (ed.), Phenothiazines and 1,4-benzothiazines. Chemical and biological aspects. Bioactive Molecules. Vol. 4, Elsevier, 1988, pp705-770.
2. Motohashi, N.; Gollapudi, S.R.; Emrani, J.; Bhattiprolu, K.R. (1991) Cancer Invest., 9, 305-319.
3. Okano, T.; Horie, T.; Motohashi, N.; Watanabe, Y.; Nishimiya, Y. (1975) Gann, 66, 529-537.
4. Kamata, K.; Motohashi, N. (1989) Anticancer Res., 9, 579-582.
5. Kamata, K.; Motohashi, N. (1989) Bull. Environ. Contam. Toxicol., 43, 534-540.
6. Kamata, K.; Motohashi, N. (1986) Neoplasma, 33, 313-322.
7. Molnár, J.; Petofi, S.; Kurihara, T.; Sakagami, H.; Motohashi, N. (1993) Anticancer Res., 13, 263-266.
8. Motohashi, N.; Kurihara, T.; Sakagami, H.; Molnár, J. (1992) Anticancer Res., 12, 2105-2108.
9. Motohashi, N.; Sakagami.; H.; Kurihara, T.; Csuri, K.; Molnár, J. (1992) Anticancer Res., 12, 135-139.
10. Kurihara, T.; Sakagami, H.; Molnár, J.; Motohashi, N. (1994) Anticancer Res., 14, 1811-1822.
11. Kurihara, T.; Motohashi, N.; Pang, G.L.; Higano, M.; Kiguchi, K.; Molnár, J. (1996) Anticancer Res., 16, 2757-2765.
12. Tanaka, M.; Csuri, K.; Molnár, J.; Motohashi, N. (1996) Anticancer Res., 16, 2837-2841.
13. Kurihara, T.; Watanabe, T.; Yoshikawa, K.; Motohashi, N. (1998) Anticancer Res., 18, 429-432.
14. Motohashi, N.; Mitscher, L.A.; Meyer, R. (1991) Med. Res. Rev., 11, 239-294.
15. Pusztai, R.; Motohashi, N.; Parkányi, C.; Aaron, J.J.; Rao, B.K.; Molnár, J. (1996) Anticancer Res., 16, 2961-2964.
16. Okano, T.; Horie, T.; Motohashi, N. (1976) Yakugaku Zasshi, 96, 891-898.
17. Motohashi, N.; Sasaki, Y.; Wakabayashi, Y.; Sakagami, H.; Molnar, J.; Kurihara, T. (1992) Anticancer Res., 12, 1423-1426.
18. Motohashi, N.; Kurihara, T.; Yamanaka, W.; Satoh, K.; Sakagami, H.; Molnár, J. (1997) Anticancer Res., 17, 3431-3435.
19. Motohashi, N.; Kurihara, T.; Satoh, K.; Sakagami, H.; Mucsi, I.; Pusztai, R.; Szabo, M.; Molnár, J. (1999) Anticancer Res., 19, 1837-1842.
20. Petri, I.B.; Szekeres, E.; Berek, I.; Molnár, J.; Sakagami, H.; Motohashi, N. (1993) Anticancer Res., 13, 2273-2275.
21. Molnár, J.; Mandi, Y.; Petri, I.; Petofi, S.; Sakagami, H.; Kurihara, T.; Motohashi, N. (1993) Anticancer Res., 13, 439-442.
22. Molnár, J.; Mandi, Y.; Foldes, J.; Foldeak, S.; Molnár, M.; Motohashi, N. (1995) In Vivo., 9, 463-468.
23. Szabo, M.; Molnar, J.; Csiszar, J.; Motohashi, N. (1995) Anticancer Res., 15, 2113-2116.
24. Molnár, J.; Pusztai, R.; Hever, A.; Nagy, S.; Motohashi, N. (1995) Anticancer Res., 15, 2013-2016.
25. Szabo, M.; Csiszar, J.; Rausch, H.; Molnar, J.; Motohashi, N. (1997) Anticancer Res., 17, 2049-2056.
26. Satoh, K.; Sakagami, H.; Motohashi, N. (1997) Anticancer Res., 17, 2539-2543.
27. Tanaka, M.; Wayda, K.; Molnár, J.; Motohashi, N. (1996) Anticancer Res., 16, 3625-3628.
28. Tanaka, M.; Wayda, K.; Molnár, J.; Parkanyi, C.; Aaron, J.J.; Motohashi, N. (1997) Anticancer Res., 47, 839-842.
29. Mucsi, I.; Molnár, J.; Motohashi, N. (2001) Int. J. Antimicrob. Agents, 18, 67-72.
30. Mucsi, I.; Varga, A.; Kawase, M.; Motohashi, N.; Molnár, J. (2002) Anticancer Res., 22, 2833-2836.
31. Motohashi, N.; Kawase, M.; Saito, S.; Sakagami, H. (2000) Curr. Drug Targets, 1, 237-245.
32. Molnar, J.; Sakagami, H.; Motohashi, N. (1993) Anticancer Res., 13, 1019-1025.
33. Motohashi, N. (1991) Anticancer Res., 11, 1125-1164.
34. Motohashi, N. (1983) In Japanese. Yakugaku Zasshi, 103, 364-371.
35. Okano, T.; Haga, M.; Takashi, K.; Nakamoto, S.; Motohashi, N. (1977) in Japanese. Yakugaku Zasshi, 97, 430-439.
36. Motohashi, N.; Kamata, K.; Meyer, R. (1990) Anticancer Res., 10, 1611-1614.
37. Motohashi, N.; Kawase, M.; Kurihara, T.; Hever, A.; Nagy, S.; Ocsocvszki, I.; Tanaka, M.; Molnár, J. (1996) Anticancer Res., 16, 2525-2532.
38. Nagy, S.; Argyelan, G.; Molnár, J, Kawase, M.; Motohashi, N. (1996) Anticancer Res., 16, 1915-1918.
39. Wuonola, M.A.; Palfreyman, M.G.; Motohashi, N.; Kawase, M.; Gabay, S.; Molnár, J. (1997) Anticancer Res., 17, 3425-3429.
40. Wuonola, M.A.; Palfreyman, M.G.; Motohashi, N.; Kawase, M.; Gabay, S.; Nacsa, J.; Molnár, J. (1997) Anticancer Res., 17, 3409-3423.
41. Wuonola, M.A.; Palfreyman, M.G.; Motohashi, N.; Kawase, M.; Gabay, S.; Gupta, R.R.; Molnár, J. (1998) Anticancer Res., 18, 337-348.
42. Motohashi, N.; Sakagami, H.; Komatsu, N.; Fujimaki, M.; Wada, C.; Molnár, J. (1992) In Vivo, 6, 585-588.
43. Szabo, M.; Molnár, J.; Banfalvi, Z.; Motohashi, N. (1992) Anticancer Res., 12, 1667-1670.
44. Motohashi, N.; Sakagami, H.; Kurihara, T.; Ferenczy, L.; Csuri, K.; Molnár, J. (1992) Anticancer Res., 12, 1207-1210.
45. Motohashi, N.; Kurihara, T.; Kawase, M.; Hever, A.; Tanaka, M.; Szabo, D.; Nacsa, J.; Yamanaka, W.; Kerim, A.; Molnár, J. (1997) Anticancer Res., 17, 3537-3543.
46. Komatsu, N.; Motohashi, N.; Fujimaki, M.; Molnár, J. (1997) In Vivo, 11, 13-16.
47. Molnár, J.; Tarodi, B.; Galfi, M.; Matkovics, B.; Motohashi, N. (1992) Anticancer Res., 12, 273-280.
48. Molnár, J.; Szabo, D.; Mandi, Y.; Mucsi, I.; Fischer, J.; Varga, A.; König, S.; Motohashi, N. (1998) Anticancer Res., 18, 3033-3038.
49. Kolaczkowski, M.; Michalak, K.; Motohashi, N. (2003) Int. J. Antimicrob. Agents, 22, 279-283.
50. Petri, I.B.; Szekeres, E.; Varga, E.; Berek, I.; Molnár, J.; Berek, L.; Kawase, M.; Motohashi, N. (1996) Anticancer Res., 16, 1247-1250.
51. Kurihara, T.; Motohashi, N.; Kobayashi, H.; Yamanaka, W.; Dohyashiki, S.; Molnar, J. (1998) Anticancer Res., 18, 3493-3497.
52. Miskolci, C.; Labadi, I.; Kurihara, T.; Motohashi, N.; Molnár J. (2000) Int. J. Antimicrob. Agents., 14, 243-247.
53. Motohashi, N.; Kurihara, T.; Satoh, K.; Sakagami, H.; Molnár, J. (1997) Anticancer Res., 17, 4403-4406.
54. Kurihara, T.; Motohashi, N.; Sakagami, H.; Molnár, J. (1999) Anticancer Res., 19, 4081-4083.
55. Kurihara, T.; Nojima, K.; Sakagami, H.; Motohashi, N.; Molnár, J. (1999) Anticancer Res., 19, 3895-3899.
56. Motohashi, N.; Kurihara, T.; Sakagami, H.; Szabo, D.; Csuri, K.; Molnár, J. (1999) Anticancer Res., 19, 1859-1864.
57. Sakagami, H.; Takahashi, H.; Yoshida, H.; Yamamura, M.; Fukuchi, K.; Gomi, K.; Motohashi, N.; Takeda, M. (1995) Anticancer Res., 15, 2533-2540.
58. Motohashi, N.; Sakagami, H.; Kamata, K.; Yamamoto, Y. (1991) Anticancer Res., 11, 1933-1938.
59. Satoh, K.; Sakagami, H.; Kurihara, T.; Motohashi, N. (1997) Anticancer Res., 17, 2465-2470.
60. Zhelev, Z.; Ohba, H.; Bakalova, R.; Hadjimitova, V.; Ishikawa, M.; Shinohara, Y.; Baba, Y. (2004) Cancer Chemother. Pharmacol., 53, 267-275.
61. GilAd, I.; Shtaif, B.; Levkovitz, Y.; Dayag, M.; Zeldich, E.; Weizman, A. (2004) J. Mol. Neurosci., 22, 189-198.
62. Karmakar, P.; Natarajan, A.T.; Poddar, R.K.; Dasgupta, U.B. (2001) Toxicol. Lett., 125, 19-28.
63. Rodrigues, T.; Santos, A.C.; Pigoso, A.A.; Mingatto, F.E.; Curti, C. (2002) Br. J. Pharmacol., 136, 136-142.
64. Shin, S.Y.; Kim, S-Y.; Kim, J-H.; Min, D.S.; Ko, J.; Kang, U-G.; Kim, Y.S.; Kwon, T.K.; Han, M.Y.; Kim, Y.H.; Lee, Y.H. (2001) J. Biol. Chem., 276, 7797-7805.
65. Matsumura, S.; Kitamura, T.; Enomoto, N.; Fujita, T.; Ishigami, A.; Handa, S.; Maruyama, N.; Zheng, D.; Ikejima, K.; Takei, Y.; Sato, N. (2004) Biochem. Biophys. Res. Commun., 321, 386-390.
66. Gasiorowski, K.; Malinaka, W.; Swiatek, P.; Jaszczyszyn, A. (2003) Cell Mol. Biol. Lett., 8, 927-942.
67. Eghbal, M.A.; Tafazoli, S.; Pennefather, P.; O'brien, P.J. (2004) Chem. Biol. Interact., 151, 43-51.
68. Azuine, M.A.; Tokuda, H.; Takayasu, J.; Enjyo, F.; Mukainaka, T.; Konoshima, T.; Nishino, H.; Kapadia, G.J. (2004) Pharmacol. Res., 49, 161-169.
69. Hadjimitova, V.; Bakalova, R.; Traykov, T.; Ohba, H.; Ribarov, S. (2003) Cell Bio. Toxicol., 19, 3-12.
70. Zhang, L.; Feng, X.; McDonald, J.M. (2003) Endocrinology, 144, 4536-4543.
71. Motohashi, N.; Kawase, M.; Saito, S.; Kurihara, T.; Satoh, K.; Nakashima, H.; Pramanathan, M.; Arakaki, R.; Sakagami. H.; Molnar, J. (2000) Int. J. Antimicrob. Agents, 14, 203-207.
72. Molnár, J.; Molnár, A.; Mucsi, I.; Pinter, O.; Nagy, B.; Varga, A.; Motohashi, N. (2003) In Vivo, 17, 145-149.
73. Yanagisawa-Shiota, F.; Sakagami, H.; Kuribayashi, N.; Iida, M.; Sakagami, T.; Takeda, M. (1995) Anticancer Res., 15, 259-266.
74. Shah, A.; Motohashi, N.; Kurihara, T.; Kawase, M.; Satoh, K.; Sakagami, H.; Molnár, J. (1998) Anticancer Res., 18, 61-64.
75. Satoh, K.; Sakagami, H.; Kadofuku, T.; Kurihara, T.; Motohashi, N. (1997) Anticancer Res., 17, 3553-3558.
76. Morgan, L.R.; Rodgers, A.H.; LeBlanc, B.W.; Boue, S.M.; Yang, Y.; Jursic, B.S.; Cole, R.B. (2001) Bioorg. Med. Chem. Lett., 11, 2193-2195.